Description:
Antagonist leads intended to treat anxiety and effective TRPC5 modulator tool compounds.

Text:
Moderately potent synthetic 
agonist BTD was also identified by Schaefer, with the 
unusual feature of excellent selectivity for TRPC5 and no 
activity on TRPC4.18 BoehringerHydra disclosed high
potency xanthine antagonist leads intended to treat 
anxiety,19,20 that Bon and coworkers characterised as 
effective TRPC5 modulator tool compounds21; Bon 
developed these xanthines further to reach intriguing 
selectivity and mixed agonistantagonist profiles (AM237; 
Fig 1a)22 as well as identify the Pico145 binding site23,24.
